Literature DB >> 16316738

Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin.

Anchang Liu1, Hongxiang Lou, Lixia Zhao, Peihong Fan.   

Abstract

To study pharmacokinetic properties of curcumin, a fast sensitive assay method was developed to determine curcumin and its metabolite tetrahydrocurcumin in rat plasma. The assay was based on tandem mass spectrometry detection (LC/MS/MS). Salbutamol was used as the internal standard (IS). The method had the lower limit of quantitation (LLOQ) of 0.5 ng/ml in rat plasma, which corresponds to 2.5 pg for the 5 microl injection volume. Good linearity was got to 500 ng/ml. The precision, accuracy, recovery and applicability were found to be adequate for pharmacokinetic studies. Phospholipid complex of the natural compound curcumin was prepared in order to improve its bioavailability. Complex formation resulted in an obvious increase in bioavailability of curcumin in rat in vivo according to the assay by above LC/MS/MS method.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316738     DOI: 10.1016/j.jpba.2005.09.032

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  45 in total

Review 1.  Heterologous production of curcuminoids.

Authors:  J L Rodrigues; K L J Prather; L D Kluskens; L R Rodrigues
Journal:  Microbiol Mol Biol Rev       Date:  2015-03       Impact factor: 11.056

Review 2.  Curcumin and lung cancer--a review.

Authors:  Hiren J Mehta; Vipul Patel; Ruxana T Sadikot
Journal:  Target Oncol       Date:  2014-05-21       Impact factor: 4.493

3.  Improvement of bioavailability and anti-inflammatory potential of curcumin in combination with emu oil.

Authors:  Manish Kumar Jeengar; Shweta Shrivastava; Kala Nair; Sreenivasa Reddy Singareddy; Uday Kumar Putcha; M V N Kumar Talluri; V G M Naidu; Ramakrishna Sistla
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

Review 4.  Protective Effects of Curcumin Against Ischemia-Reperfusion Injury in the Nervous System.

Authors:  Kowsar Bavarsad; George E Barreto; Mousa-Al-Reza Hadjzadeh; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-06-09       Impact factor: 5.590

Review 5.  Discovery of curcumin, a component of golden spice, and its miraculous biological activities.

Authors:  Subash C Gupta; Sridevi Patchva; Wonil Koh; Bharat B Aggarwal
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-03       Impact factor: 2.557

6.  Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice.

Authors:  Kwok Kin Cheng; Chin Fung Yeung; Shuk Wai Ho; Shing Fung Chow; Albert H L Chow; Larry Baum
Journal:  AAPS J       Date:  2012-12-11       Impact factor: 4.009

Review 7.  Molecular targets of curcumin for cancer therapy: an updated review.

Authors:  Pandima Devi Kasi; Rajavel Tamilselvam; Krystyna Skalicka-Woźniak; Seyed Fazel Nabavi; Maria Daglia; Anupam Bishayee; Hamidreza Pazoki-Toroudi; Seyed Mohammad Nabavi
Journal:  Tumour Biol       Date:  2016-07-28

Review 8.  Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.

Authors:  Avijit Sarkar; Ronita De; Asish K Mukhopadhyay
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

9.  Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells.

Authors:  Rajesh L Thangapazham; Anu Puri; Shrikant Tele; Robert Blumenthal; Radha K Maheshwari
Journal:  Int J Oncol       Date:  2008-05       Impact factor: 5.650

10.  Curcumin induces apoptosis-independent death in oesophageal cancer cells.

Authors:  G O'Sullivan-Coyne; G C O'Sullivan; T R O'Donovan; K Piwocka; S L McKenna
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.